Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2022-09-19 Purchase |
2022-09-20 6:08 pm |
Cardiff Oncology Inc. | CRDF | White Lale Director |
15,000 | $1.635 | $24,525 | 113,788 (Indirect) |
View |
2022-09-15 Purchase |
2022-09-19 08:37 am |
Cardiff Oncology Inc. | CRDF | TANNENBAUM RENEE P Director |
10,000 | $1.7168 | $17,168 | 10,000 (Direct) |
View |
2022-09-15 Purchase |
2022-09-19 08:37 am |
Cardiff Oncology Inc. | CRDF | PACE GARY W Director |
150,000 | $1.71 | $256,500 | 644,811 (Direct) |
View |
2022-09-16 Purchase |
2022-09-19 08:37 am |
Cardiff Oncology Inc. | CRDF | Levine James E. Chief Financial Officer |
30,000 | $1.557 | $46,710 | 60,000 (Direct) |
View |
2021-09-21 Purchase |
2021-09-22 5:54 pm |
Cardiff Oncology Inc. | CRDF | PACE GARY W Director |
30,000 | $6.75 | $202,500 | 494,811 (Direct) |
View |
2021-09-10 Purchase |
2021-09-13 08:12 am |
Cardiff Oncology Inc. | CRDF | Levine James E. Chief Financial Officer |
30,000 | $6.4667 | $194,000 | 30,000 (Direct) |
View |
2021-03-19 Purchase |
2021-05-27 5:14 pm |
Cardiff Oncology Inc. | CRDF | Armitage James O Director |
4,000 | $10.82 | $43,271 | 14,490 (Direct) |
View |
2021-03-26 Purchase |
2021-03-29 1:38 pm |
Cardiff Oncology Inc. | CRDF | Markin Rodney S Director |
2,900 | $10.32 | $29,933 | 31,060 (Indirect Direct) |
View |
2021-03-23 Purchase |
2021-03-24 10:27 am |
Cardiff Oncology Inc. | CRDF | PACE GARY W Director |
10,000 | $10.23 | $102,300 | 464,811 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2022-07-05 Exercise |
2022-07-06 4:10 pm |
2021-06-17 2030-06-17 |
Cardiff Oncology Inc. | CRDF | White Lale Director |
28,858 | $2.6 | 159,504 (Direct) |
View |
2022-06-09 Other |
2022-06-09 7:48 pm |
2022-06-09 2024-06-09 |
Cardiff Oncology Inc. | CRDF | BRANCACCIO JOHN P Former Director Director |
124,318 | $0 | 1,127,853 (Direct) |
View |
2022-03-09 Option Award |
2022-03-11 2:11 pm |
2023-03-09 2032-03-09 |
Cardiff Oncology Inc. | CRDF | PACE GARY W Director |
26,800 | $0 | 89,574 (Direct) |
View |
2022-03-09 Option Award |
2022-03-10 6:43 pm |
2023-03-09 2032-03-09 |
Cardiff Oncology Inc. | CRDF | White Lale Director |
26,800 | $0 | 89,574 (Direct) |
View |
2022-03-09 Option Award |
2022-03-10 6:43 pm |
2023-03-09 2032-03-09 |
Cardiff Oncology Inc. | CRDF | TANNENBAUM RENEE P Director |
26,800 | $0 | 70,801 (Direct) |
View |
2022-03-09 Option Award |
2022-03-10 6:42 pm |
N/A 2032-03-09 |
Cardiff Oncology Inc. | CRDF | Ruffner Katherine L Chief Medical Officer |
170,016 | $0 | 370,016 (Direct) |
View |
2022-03-09 Option Award |
2022-03-10 6:42 pm |
2023-03-09 2032-03-09 |
Cardiff Oncology Inc. | CRDF | Mohindru Mani Director |
26,800 | $0 | 70,801 (Direct) |
View |
2022-03-09 Option Award |
2022-03-10 6:41 pm |
2023-03-09 2032-03-09 |
Cardiff Oncology Inc. | CRDF | Markin Rodney S Director |
26,800 | $0 | 124,627 (Direct) |
View |
2022-03-09 Option Award |
2022-03-10 6:40 pm |
N/A 2032-03-09 |
Cardiff Oncology Inc. | CRDF | Levine James E. Chief Financial Officer |
170,016 | $0 | 560,016 (Direct) |
View |
2022-03-09 Option Award |
2022-03-10 6:40 pm |
N/A 2032-03-09 |
Cardiff Oncology Inc. | CRDF | Kelemen Vicki Exec. VP and COO |
170,016 | $0 | 572,784 (Direct) |
View |
2022-03-09 Option Award |
2022-03-10 6:39 pm |
N/A 2032-03-09 |
Cardiff Oncology Inc. | CRDF | Erlander Mark Chief Executive Officer |
370,128 | $0 | 1,185,400 (Direct) |
View |
2022-03-09 Option Award |
2022-03-10 6:38 pm |
2023-03-09 2032-03-09 |
Cardiff Oncology Inc. | CRDF | BRANCACCIO JOHN P Director |
26,800 | $0 | 125,317 (Direct) |
View |
2022-03-09 Option Award |
2022-03-10 6:38 pm |
2023-03-09 2032-03-09 |
Cardiff Oncology Inc. | CRDF | Armitage James O Director |
26,800 | $0 | 89,574 (Direct) |
View |
Ownership |
2022-01-14 1:34 pm |
N/A 2032-01-10 |
Cardiff Oncology Inc. | CRDF | Smeal Tod Chief Scientific Officer |
0 | $0 | 275,088 (Direct) |
View |
2021-07-12 Option Award |
2021-07-14 4:00 pm |
N/A 2031-07-12 |
Cardiff Oncology Inc. | CRDF | Ruffner Katherine L Chief Medical Officer |
200,000 | $0 | 200,000 (Direct) |
View |
2021-07-12 Option Award |
2021-07-12 4:16 pm |
N/A 2031-07-12 |
Cardiff Oncology Inc. | CRDF | Levine James E. Chief Financial Officer |
390,000 | $0 | 390,000 (Direct) |
View |
2021-06-10 Other |
2021-06-15 10:06 am |
2021-06-10 2023-06-10 |
Cardiff Oncology Inc. | CRDF | JACOB GARY S Former Director Director |
75,834 | $0 | 608,848 (Direct) |
View |
2021-06-10 Option Award |
2021-06-14 4:14 pm |
2022-06-10 2031-06-10 |
Cardiff Oncology Inc. | CRDF | White Lale Director |
22,000 | $0 | 62,774 (Direct) |
View |
2021-06-10 Option Award |
2021-06-14 4:13 pm |
N/A 2031-06-10 |
Cardiff Oncology Inc. | CRDF | TANNENBAUM RENEE P Director |
44,001 | $0 | 44,001 (Direct) |
View |
2021-06-10 Option Award |
2021-06-14 4:13 pm |
2022-06-10 2031-06-10 |
Cardiff Oncology Inc. | CRDF | PACE GARY W Director |
22,000 | $0 | 62,774 (Direct) |
View |
2021-06-10 Option Award |
2021-06-14 4:12 pm |
N/A 2031-06-10 |
Cardiff Oncology Inc. | CRDF | Mohindru Mani Director |
44,001 | $0 | 44,001 (Direct) |
View |
2021-06-10 Option Award |
2021-06-14 4:12 pm |
2022-06-10 2031-06-10 |
Cardiff Oncology Inc. | CRDF | Markin Rodney S Director |
22,000 | $0 | 97,827 (Direct) |
View |
2021-06-10 Option Award |
2021-06-14 4:12 pm |
N/A 2031-06-10 |
Cardiff Oncology Inc. | CRDF | Kelemen Vicki Exec. VP and COO |
200,928 | $0 | 402,768 (Direct) |
View |
2021-06-10 Option Award |
2021-06-14 4:11 pm |
N/A 2031-06-10 |
Cardiff Oncology Inc. | CRDF | Erlander Mark Chief Executive Officer |
435,072 | $0 | 815,272 (Direct) |
View |
2021-06-10 Option Award |
2021-06-14 4:11 pm |
2022-06-10 2031-06-10 |
Cardiff Oncology Inc. | CRDF | BRANCACCIO JOHN P Director |
22,000 | $0 | 98,517 (Direct) |
View |
2021-06-10 Option Award |
2021-06-14 4:11 pm |
2022-06-10 2031-06-10 |
Cardiff Oncology Inc. | CRDF | Armitage James O Director |
22,000 | $0 | 62,774 (Direct) |
View |
2021-06-10 Other |
2021-06-14 4:10 pm |
N/A 2023-06-10 |
Cardiff Oncology Inc. | CRDF | ADAMS THOMAS PHD Former Director Director |
473,468 | $0 | 3,345,090 (Direct) |
View |